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Abstract
Background: Dendritic cells (DCs) are antigen presenting cells capable of inducing innate and
adaptive immune responses. According to the stimulus and their maturation state, DCs induce
immunogenic or tolerogenic responses. Platelets (PLTs), which are involved in haemostasis and
inflammation, can also interact with DCs. In this study, we examined the effect of PLTs on DC
maturation in vitro. Human monocyte-derived DCs were co-cultured for 2 days with homologous
PLTs either in the same well or in 0.4 μm-pore size filter-separated compartments.
Results: Confocal microscopy showed the attachment of PLTs to DC membranes. The DC
receptor involved in this interactions was found to be CD162. In addition, we observed that DCs
co-cultured with PLTs in filter-separated compartments acquired a mature phenotype (high CD80,
CD86, and intermediate CD83 expression; IL-12(p70) production; efficient stimulation of
autologous CD4+ T cell proliferation), while DCs co-cultured with PLTs in the same compartment
did not undergo phenotypic maturation, did not secrete IL-12(p70) or IL-1β, but instead induced
moderate Th2-polarized T cell proliferation.
Conclusion: These data indicate that (i) PLTs secrete a soluble DC-activating factor that was
demonstrated not to be soluble CD40-Ligand (CD154; as could have been expected from in vivo
and previous in vitro work) but to be nucleotide, and (ii) that cell-to-cell contact did not induce DC
maturation, possibly because nucleotide release by PLTs was prevented by direct contact with
DCs. This work demonstrates that PLTs are active elements of the immune system that might play
a role in balancing the ability of DCs to polarize T cell responses, therefore making them critical
factors in transfusion processes.
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Background
Dendritic cells (DCs) are sentinels of the immune system,
involved in innate and adaptive immunity, the role of
which is to guard the periphery for signs of foreign inva-
sion. Recognition of pathogens by immature DCs is medi-
ated by a set of receptors that includes Toll-like receptors
(TLRs) [1], Fc-receptors [2], and C-type lectins [3]. Upon
a "danger signal", immature DCs develop into mature
immunostimulatory DCs. The DC maturation program
includes a change in the expression profile of chemokine
receptors, enabling the maturing DCs to migrate toward
draining lymph nodes [4].
Maturing DCs overexpress costimulatory molecules
(CD80, CD83, and CD86) and molecules involved in
antigen presentation (Major Histocompatibility Complex
class I and II) on their membranes. Matured DCs promote
CD4+ or CD8+ T cell and B cell activation [5], and also
interact with NK cells [6]. In addition, DCs can select the
type of immune response by polarizing lymphocytes
towards Th1, Th2, or Treg response profiles. The balance
between these three types of responses depends not only
on the inducing-signal, i.e., the nature of the foreign anti-
gen [1], but also on the maturation state of DCs [7]. This
aspect could be of particular importance during transfu-
sion practices, which imply homologous cells such as
platelets (PLTs).
In addition to their haemostatic role, PLTs have been
shown to play a part in inflammation [8] and in innate [9]
and adaptive immune responses [10]. Furthermore, DC
susceptibility to PLT-derived components has already
been observed [11,12], and several studies have shown
that activated PLTs can modulate DC activation [10,11].
However, during transfusions, transfused homologous
PLTs that are not activated and might also act on DCs.
In this work, we investigated the influence of homologous
PLTs on DC activation status. We observed that PLTs co-
cultured with DCs in a filter-separated compartment
released nucleotides that induced maturation of DCs, as
shown by an overexpression of costimulatory molecules,
IL-12(p70) production, and stimulation of autologous
CD4+ T cell proliferation. In contrast, DCs co-cultured in
direct contact with PLTs remained phenotypically imma-
ture, did not produce IL-12(p70) and IL-1β, and induced
only a weak Th2-polarized T cell proliferation. These data
indicate that PLTs affect DC activation differently depend-
ing on whether when they are in close contact with DCs or
not.
Methods
Culture medium and cytokines
Both PLTs and monocyte-derived DCs were maintained in
RPMI 1640 supplemented with L-glutamine (Abcys, Paris,
France) and 1% penicillin-streptomycin solution (Sigma
Aldrich, Saint-Quentin, France), hereafter called minimal
medium. For DC differentiation, the culture medium was
supplemented with 10% heat-inactivated endotoxin-free
fetal calf serum (FCS; Invitrogen, Cergy Pontoise, France),
recombinant human granulocyte macrophage-colony
stimulating factor (GM-CSF; specific activity: 107 U/mg)
and IL-4 (specific activity: 5 × 106  U/mg; Peprotech,
Abcys).
Monocyte purification and culture
Peripheral blood from healthy donors (provided by the
Auvergne-Loire Regional Blood Bank) was divided into
two parts, one part for monocyte purification and the
other for CD4+ T cell isolation. Mononuclear cells were
obtained by centrifugation on Histopaque®1077 (Sigma
Aldrich) and monocytes were depleted of NK, T, and B
cells using mouse anti-CD2, CD7, CD16, CD19, CD56,
and CD235a (glycophorin A) monoclonal antibodies
(mAbs) and anti-mouse Ig coupled to magnetic
microbeads, according to the manufacturer's instructions
(Dynal/Invitrogen, Cergy Pontoise, France). The tech-
nique routinely results in > 90% purified CD14-express-
ing cells and cell viability was greater than 95%, as
determined by Trypan blue exclusion. Monocytes (106
cells/ml) were cultured for 5 days in six-well tissue culture
plates (BD Falcon™, Becton Dickinson, Le-Pont-de-Claix,
France) in minimal medium supplemented with 10% FCS
(Myoclone®, Invitrogen), recombinant human GM-CSF
(400 U/ml) and IL-4 (660 U/ml), to produce DCs [13].
On days 2 and 4, cells were fed with fresh medium and
cytokines. After 5 days in culture, all cells expressed CD1a,
neither CD14 nor CD83, low levels of costimulatory mol-
ecules and, as described previously, CD162 [14].
Platelet isolation
Platelet concentrates used for this study were rigorously
identical as required for French transfusion purposes.
Briefly, blood from volunteer healthy donors and PLT
concentrate mixtures starting from buffy coats were pre-
pared at the Auvergne-Loire Regional Blood Bank. Buffy
coats were stored at 20°C without agitation for 2 h. Then,
five buffy coats and a storage solution (T-sol®, Baxter,
Maurepas, Belgium) were pooled and centrifuged. The
PLT-rich supernatant was collected and leukofiltrated
under pressure in order to remove residual leukocytes to
below 105 leukocytes/3.5 × 1011 PLTs, according to the
French Blood Bank routine procedures. To minimize the
transport of soluble proteins bound on PLT membranes
and to avoid any alteration of PLT phenotype in our study,
we used an established PLT washing method that prevents
transitory platelet activation during the preparation [15].
Briefly, platelets were washed twice in Tyrode's buffer sup-
plemented with apyrase (0.02 U/mL) and prostacyclin
(0.5 mM) and resuspended in the same buffer. These pro-BMC Immunology 2008, 9:54 http://www.biomedcentral.com/1471-2172/9/54
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cedures induce moderate PLT activation, with low CD62P
expression (almost 15%), but do not interfere with trans-
fusion grade status of purified PLTs [9].
Dendritic cell/platelet co-culture
Co-cultures were maintained in serum-free medium in
order to avoid FCS-induced PLT activation, as described
by Hilf et al. [11]. DCs (5 × 105) were co-cultured in 3 ml
of minimal medium for 2 days with 1.5 × 107 homolo-
gous PLTs (DC:PLT ratio, 1:30) either in the same com-
partment or in 0.4-μm pore-sized filter-separated
compartments in a six-well culture plate (Corning Costar/
Fisher Bioblock Scientific, Illkirch, France). PLTs and DCs
were not derived from the same donor in order to mimic
most PLT transfusion practices in which recipients receive
homologous PLTs. The 0.4-μm-pore-sized filter enables
soluble factor diffusion while blocking direct cell-to-cell
contact. As negative controls, DCs and PLTs were cultured
alone in minimal medium without significant mortality,
as assessed by Trypan blue exclusion. As positive controls,
DCs were treated for 48 h with 100 ng/ml of purified sol-
uble trimeric human CD154 (sCD154; a kind gift from
Immunex-Amgen Corp., Seattle, WA, USA) or with 500
ng/ml of E. coli 0111:B4 lipopolysaccharide (LPS; Calbio-
chem/VWR, Strasbourg, France) and PLTs were treated for
30 min with 1 U/ml of thrombin (Calbiochem/VWR). To
determine whether soluble factors released by platelets
during co-culture could be involved in DC activation,
both untreated and 1% paraformaldehyde-fixed PLTs [11]
were used in co-culture. In order to determine the impor-
tance of PLT-binding in DC-PLT interactions during co-
culture, DCs were incubated for 1 h at 37°C prior to co-
culture and during the entire co-culture period with 10
μg/ml of anti-human CD162 blocking mouse mAb [16]
(PL1 clone, Immunotech Beckman-Coulter, Marseille,
France). Finally, to assess the involvement of PLT-derived
nucleotides (adenosine diphosphate (ADP) and adenos-
ine triphosphate (ATP)) in DC activation during co-cul-
ture, DCs were incubated for 1 h at 37°C prior to co-
culture and during the entire co-culture period with 30
μM of the broad-spectrum P2 receptor antagonist suramin
(Sigma-Aldrich) [17]. Then, supernatants were recovered
for cytokine/chemokine content analysis and cells were
washed twice with minimal medium. Half of the DCs
(i.e., 2.5 × 105 cells) was stained and analyzed either by
flow cytometry or confocal microscopy. CD1a expression
on DCs was confirmed after co-culture with PLTs in order
to rule out any reversion of DC differentiation. The other
half of the DCs was used for autologous T cell activation.
Flow cytometry
Cells were incubated for 30 min at 4°C with 10% FCS-PBS
and affinity-purified mouse mAb at the appropriate con-
centration or irrelevant isotype-matched mouse Igs at the
same concentration and then washed. The following
mAbs were used: anti-CD1a-Allophycocyanin (APCy),
anti-CD40-PE, anti-CD41-FITC, anti-CD41-APCy, anti-
CD62P-PE, anti-CD80-PE, anti-CD83-PE, anti-CD86-PE,
anti-CD162-PE, and anti-CD209-PE (all from Becton
Dickinson-PharMingen). To avoid non-specific antibody
binding, all staining experiments were performed in the
presence of Fc-receptor blocking reagent (Miltenyi Biotec,
Paris, France). Fluorescence analysis was performed on a
FACSCalibur using CellQuestPro software (Becton Dick-
inson-Biosciences).
Platelet binding assay
To determine the DC receptors involved in PLT binding,
DCs (2.5 × 105) were incubated, or not, with 7.5 × 106
PLTs (DC:PLT ratio, 1:30) for 1 h at room temperature to
allow PLT binding without affecting DC phenotype. DCs
were then stained for potential PLT receptors. In addition,
to investigate the involvement of CD162 and DC-SIGN in
PLT binding, DCs were incubated with with 10 μg/ml of
anti-human CD162 blocking mouse mAb [16] (PL1
clone, Immunotech Beckman-Coulter), 100 mM mannan
(Sigma-Aldrich), or 10 μg/ml of isotype-matched irrele-
vant mouse antibody. Cells were then washed and incu-
bated for 1 h at room temperature with PLTs, washed
extensively to avoid non-specific binding, stained for
CD1a and CD41 expression, and then analyzed by flow
cytometry.
Confocal microscopy
DCs co-cultured with PLTs in the same compartment were
stained at 4°C for 30 min with mouse anti-human CD209
antibody and Alexa Fluor® 555 goat anti-mouse IgG (H+L)
and then with anti-CD41-FITC mAb, washed and fixed at
room temperature for 20 min in a 4% paraformaldehyde-
PBS solution. Stained cells were washed and resuspended
in Vectashield® mounting medium (Vector Laboratories
Ltd., Abcys), mounted on a glass slide, and covered by a
cover slip. Visualization was performed on a TCS SP2
Leica confocal microscope equipped with an AOBS and a
63 ×/1.4 oil-immersion objective lens with a 2.2 zoom
(all from Leica Microsystèmes SAS, Rueil-Malmaison,
France). Images were acquired using a dual-band 488-nm
argon and 543-nm helium/neon laser and were collected
using Leica Confocal Software.
Cytokine analysis
Tumor necrosis factor α(TNF-α), IL-10, IL-12(p70), IL-1β,
and RANTES content in the supernatants from co-cultured
cells or cells cultured alone, and in the presence or
absence of sCD154 or LPS, was measured using Luminex®
technology (Beadlyte® Multiplex Testing Service, Upstate,
Dundee, UK). Soluble CD62P, sCD40L, IL-2, and IL-4
content in culture supernatants was measured by specific
ELISA using commercial kits (R&D Systems Europe Ltd,BMC Immunology 2008, 9:54 http://www.biomedcentral.com/1471-2172/9/54
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Lille, France) according to the manufacturer's instruc-
tions.
RANTES mRNA analysis
DCs and PLTs were cultured separately or together for 2
days as described in "dendritic cell/platelet coculture" sec-
tion. Cells were collected and mRNA was extracted using
a Genelute direct mRNA miniprep kit (Sigma-Aldrich)
according to manufacturer's instructions. After DNAse I
treatment, 1 mg mRNA was retro-transcribed with M-
MuLV reverse transcriptase (Promega, Charbonières,
France) and fragments were amplified with Taq polymer-
ase (Sigma-Aldrich) using primers specific for human
RANTES and for β-actin (R&D Systems Europe Ltd, Lille,
France), as described previously [18]. Expected product
lengths were 320 bp for RANTES internal positive control,
198 bp for RANTES complementary DNA (cDNA), and
634 bp for β-actin cDNA. Amplification products were
resolved by electrophoresis and product sizes were veri-
fied against a 100 bp DNA ladder (Invitrogen).
Autologous T cell activation
For each experiment, CD4+ T cells were purified from the
mononuclear cells of the same blood sample from which
the monocytes were derived using the Dynabeads®
MyPure™ CD4 T Cell Kit 2 (For Untouched Human Cells;
Dynal/Invitrogen). Briefly, CD4+ T cells were depleted of
NKs, monocytes, and B cells using mouse anti-CD8,
CD14, CD16 (specific for CD16a and CD16b), CD19,
CD36, CD56, CDw123, and CD235a (glycophorin A)
mAbs and anti-mouse Ig coupled to magnetic
microbeads, according to the manufacturer's instructions.
The technique routinely results in >95% purified CD4-
expressing cells and cell viability was greater than 95%, as
determined by Trypan blue exclusion. After washing, cells
were frozen until use. Once thawed, CD4+ autologous T
cells were labeled with carboxyfluorescein diacetate suc-
cinimidyl ester (CFSE, Invitrogen). Cells were first washed
in RPMI1640 without FCS and then incubated with 5 μM
of CFSE at 37°C for 20 min. The reaction was stopped by
adding FCS. Cells were washed extensively and resus-
pended at 2.5 × 106 cells/ml in 10% FCS-supplemented
RPMI1640. In parallel, DCs from the different co-culture
conditions with PLTs were resuspended at 2.5 × 105 cells/
ml and co-cultured with 2.5 × 106 autologous CD4+ T cells
(DC:T cell ratio = 1:10) for 7 days in individual wells of
12-well round-bottom plates. Cells were then harvested
and T cell proliferation was analyzed immediately by flow
cytometry measuring the CFSE fluorescence intensity. The
percentage of CFSElow T cells in co-culture with DCs was
normalized to percentage of CFSElow in untreated T cells
(control) according to the following formula: ((%
CFSElow
co-culture - % CFSElow
control)/% CFSElow
control) × 100.
Untreated CD4+ T cells were used as negative controls and
T cells stimulated with 2.5 μg/ml phytohemagglutinin
(PHA) and 100 U/ml human recombinant IL-2 for 48 h
were used as positive controls. Finally, supernatants were
collected in order to measure secreted IL-2 and IL-4,
cytokines typical of Th1 and Th2 responses, respectively.
Statistical analysis
Inter-experiment comparisons were performed by Mann-
Whitney U test (Statistica-StatSoft, Maisons-Alfort,
France).
Results
Platelet binding to dendritic cells
As expected, PLTs did not express CD1a (Figure 1B). The
PLT-specific marker CD41 was expressed neither by
untreated DCs (Figure 1A) nor by DCs co-cultured with
homologous PLTs in filter-separated compartments (Fig-
ure 1C), confirming that no soluble CD41 is released
from PLTs and subsequently binds to DCs. However,
nearly half of the DCs co-cultured with PLTs in the same
well expressed CD41 (p < 0.05), suggesting that PLTs were
binding to the DC membrane (Figure 1D). To confirm
this observation, we analyzed the expression of CD41 and
CD209 (DC-Specific ICAM-3 Grabbing Nonintegrin, DC-
SIGN) on PLTs and DCs co-cultured in the same well by
confocal microscopy (Figure 1E–G). An attachment
between PLTs and DCs was clearly visible (Figure 1G). The
PLTs were tightly bound to the DCs and extensive washing
of the cell preparation prior to confocal microscopy and
cytometry analysis did not separate the two cell types.
Therefore, we investigated which PLT and DC receptors
were involved in PLT-DC binding. DCs were incubated
with or without PLTs for 1 h to allow PLT binding without
affecting DC phenotype. DC were washed extensively and
stained for several potential PLT receptors. We could evi-
dence that in the presence of PLTs, the percentage of
CD162-expressing DCs decreased significantly (p < 0.05)
from 78 ± 5% to 62 ± 3%, whereas the percentage of
CD209-positive DCs did not change significantly
although a small diminution seemed to occur (Figure 2A).
This observation suggests that CD162 molecules on DCs
are occupied by PLTs.
In order to confirm the involvement of CD162 in PLT-DC
binding, we incubated DCs with blocking anti-CD162
mAb prior to incubation with PLTs. We observed that the
percentage of DCs expressing CD41, reflecting the per-
centage of DCs with PLTs bound to their membrane,
decreased significantly (4 ± 3%) as compared to DCs incu-
bated with PLTs without anti-CD162 preincubation (39 ±
4%; p < 0.005; Figure 2B). In contrast, preincubation of
DCs with either 100 mM of mannan or 10 μg/ml of an
irrelevant antibody did not alter the percentage of CD41-
positive DCs (38 ± 8%). This confirms that PLTs bind to
DCs, at least in part, via the CD162 receptor on DC andBMC Immunology 2008, 9:54 http://www.biomedcentral.com/1471-2172/9/54
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Platelet binding to dendritic cells Figure 1
Platelet binding to dendritic cells. Platelet (PLT) binding to dendritic cells (DCs) was evaluated by flow cytometry (A-D) 
or by confocal microscopy (E-G). DCs and PLTs were cultured for 48 h alone (A-B) or together, either in two 0.4-μm pore-
sized filter-separated compartments (C) or in the same compartment (D). DCs and PLTs were stained for CD1a and CD41, 
respectively, and analyzed by flow cytometry (A-D). For PLTs cultured alone, flow cytometry plots are not gated on any 
marker. For DCs, flow cytometry plots are gated on CD1a+ events only. Plots are representative of five independent experi-
ments. (E-G) DCs cultured with PLTs in the same compartment were stained for CD209 and CD41 and analyzed by confocal 
microscopy (E, anti-CD41-FITC; F, anti-CD209- Alexa Fluor® 555 and G, anti-CD41-FITC, and anti-CD209- Alexa Fluor® 555). 
The confocal microscopy photograph is representative of three independent experiments.BMC Immunology 2008, 9:54 http://www.biomedcentral.com/1471-2172/9/54
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that CD209 does not participate significantly to PLT-DC
binding.
Dendritic cell activation by platelets
After 5 days in culture, monocytes differentiated into via-
ble typical DCs with a classical non-activated phenotype,
as shown in Figure 3A, displaying cytometry plots of a rep-
resentative experiment. Culture of DCs in minimal
medium for 2 days did not induce significant modifica-
tion of CD1a or costimulatory molecule expression. As
well, minimal medium did not induce a higher level of
PLT activation as compared to freshly isolated PLTs, the
latter displaying only a weak CD62P expression related to
the isolation process (Figure 3A). As a positive control for
DC activation, we treated DCs with soluble CD154
(sCD154) and observed a significant increase in the mean
expression of CD80, CD86, and CD83, which reached 73
± 8%, 90 ± 9%, and 72 ± 6%, respectively (p < 0.05; Figure
3B). When PLTs were co-cultured with DCs in filter-sepa-
rated compartments, we observed a notable proportion of
CD80-, CD86-, and CD83-positive DCs (56 ± 3%, 60 ±
7%, and 37 ± 4%, respectively), which differed signifi-
cantly from the untreated control (p < 0.05), demonstrat-
ing that PLTs induce moderate but significant DC
activation (Figure 3B). However, when PLTs were co-cul-
tured in direct contact with DCs, we observed only a slight
increase in the proportion of activated DCs, which did not
differ significantly from the untreated controls in mean
expression of CD80 (44 ± 6%), CD86 (21 ± 5%), and
CD83 (14 ± 5%; Figure 3B). Therefore, we can assume that
PLTs release soluble factors that induce DC activation and
that cell-to-cell contact between PLTs and DCs does not
promote DC activation. Indeed, when DCs were incu-
bated with a blocking anti-CD162 mAb prior to and dur-
ing co-culture with PLTs, there was a significant increase
in the mean expression of CD80 (48 ± 2%), CD86 (53 ±
4%), and CD83 (20 ± 3%) on DCs (Figure 3C), demon-
strating that PLT binding to DCs prevents the former from
activating the latter.
Moreover, PLTs fixed in 1% paraformaldehyde did not
induce a significant increase in CD80, CD86, and CD83
expression (respectively, 20 ± 3%, 32 ± 5%, 2 ± 2%), con-
firming the involvement of a soluble factor in DC activa-
tion during filter-separated co-culture with PLTs (Figure
3D). Given that PLTs release large amounts of sCD154
during their storage [19] or upon activation [20], we
investigated whether the DC activation that we observed
could have been induced by PLT-derived sCD154. How-
ever, we did not detect any sCD154 in the supernatants
from PLTs and DCs cultured separately or from co-cul-
tures of these two cell types (ELISA data not shown). We
did not observe a decrease in CD40 expression by DCs
either, indicating that the absence of sCD154 in the super-
natant could not be explained by its binding to the DC
membrane via CD40 (Figure 3A). However, the lack of
detectable sCD154 could have been related to the non-
activated status of the PLTs. Indeed, in our study, PLTs
were not submitted to any activation stimulus and did not
exhibit an activated phenotype after co-culture with DCs
(Figure 3A).
Potential dendritic cell receptors for platelets Figure 2
Potential dendritic cell receptors for platelets. Den-
dritic cells (DCs) were incubated with or without platelets 
(PLTs) for 1 h (A), or pre-incubated for 1 h with an anti-
CD162 blocking antibody, mannan, or an irrelevant antibody 
and then incubated for 1 h with PLTs (B). DCs were then 
stained for CD162 and CD209 (A) or for CD41 (B) and ana-
lyzed by flow cytometry after gating on CD1a+ cells only. The 
results presented are mean values ± SD of five independent 
experiments; percentage of marker expression in each 
experiment was assessed in triplicate. Asterisk indicates sta-
tistical significance a p < 0.05 (*) or < 0.005 (**) by Mann-
Whitney U test.
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Figure 3 (see legend on next page)
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Nucleotides such as ADP and ATP, which is known to
induce DC activation, are present in large amounts in
PLTs [17,21]. In order to investigate whether PLT-derived
nucleotides might be involved in DC activation in our sys-
tem, DCs were incubated with suramin, a broad-spectrum
P2 receptor antagonist, prior to and during filter-sepa-
rated co-culture with PLTs. We found that suramin-treated
DCs displayed an activation phenotype comparable to
that of untreated DCs (i.e., low mean expression of CD80
(21 ± 2%), CD86 (35 ± 4%), and CD83 (4± 4%); Figure
3D). Thus, during filter-separated co-culture, PLTs release
nucleotides that can activate DCs. Interestingly, DCs that
were in close contact with PLTs expressed more CD80
than CD86 (44 ± 6% vs. 21 ± 5%, respectively), whereas
DCs activated by PLTs through a filter expressed more
CD86 than CD80 (60 ± 7% vs. 56 ± 3%, respectively; Fig-
ure 3B).
Thus, filter-separated co-culture of PLTs with DCs does
not activate PLTs but induces PLT release of nucleotides
capable of maturing DCs. In contrast, when these two cell
types are co-cultured in the same well, PLTs are main-
tained in a steady state, they do not release nucleotides
and DC activation is not induced.
Cytokine production
We next investigated whether PLTs could modulate DC
function. Using the Luminex® technology, we assessed the
release of the main pro-inflammatory cytokines TNF-α,
IL-1β, and IL12-p70, in addition to RANTES which can
also be released by PLTs, by DCs cultured alone (negative
control), by sCD154 or LPS-treated DCs (positive con-
trols), and by DCs co-cultured with PLTs (Figure 4). We
found that filter-separated co-culture of PLTs with DCs, i)
inhibited TNF-α production; this inhibition was depend-
ent on the release of nucleotides by PLTs because parafor-
maldehyde fixation of PLTs and suramin treatment of
DCs restored the initial IL-1β production (Figure 4A); ii)
did not modify IL-1β (Figure 4B) or RANTES production
significantly (Figure 4D); but, iii) did induce significant
IL-12(p70) production dependent on the release of nucle-
otide by PLTs (PLT fixation and suramin treatment
reduced IL-12(p70) production to the level of the negative
control; Figure 4C). Moreover, IL-10, sCD154, and solu-
ble CD62P (sCD62P) were not detected in co-culture
supernatants (data not shown). Therefore, we found that
the activated phenotype of DCs induced by filter-sepa-
rated co-culture with PLTs was associated with the func-
tional activation of DCs, leading to IL-12(p70)
production.
On the other hand, PLTs co-cultured in direct contact with
DCs did not trigger IL-12(p70) production, unless this
contact was prevented by a blocking anti-CD162 mAb
(Figure 4C) and inhibited TNF-α (Figure 4A) and IL-1β
production (Figure 4B); however, their mechanisms of
inhibition of appear to be different. PLT fixation and
suramin-treatment of DCs did not restore TNFα produc-
tion, whereas the blocking anti-CD162 mAb did, showing
that PLT binding to DCs, and not factor release by PLTs, is
crucial for inhibiting the production of TNFα (Figure 4A).
As for the inhibition of IL-1β production, PLT fixation,
treating DCs with suramin and blocking anti-CD162 DC
treatment returned IL-1β production to its original level,
suggesting that upon binding to DCs, PLTs release nucle-
otides that inhibit IL-1β production (Figure 4B).
These observations indicate that intimate contact between
PLTs and DCs does not promote DC polarization towards
a proinflammatory response, even if we did observe a sig-
nificant increase in RANTES production (Figure 4D).
However, under these conditions, the level of RANTES
production was far less than the level induced by sCD154-
treatment of DCs or thrombin-treatment of PLTs, and was
prevented by paraformaldehyde fixation of PLTs. These
data suggest that RANTES is released by PLTs (Figure 4D;
in agreement with the results of Danese et al. [22]). We
investigated whether the increase in RANTES in the co-cul-
Activation status of dendritic cells and platelets during co-culture Figure 3 (see previous page)
Activation status of dendritic cells and platelets during co-culture. Dendritic cells (DCs) were cultured for 48 h alone 
(untreated), with sCD154, or with platelets (PLTs) either in two 0.4-μm pore-sized filter-separated compartments or in the 
same compartment. To evaluate the contribution of soluble factors released by PLTs on DC activation, PLTs were used either 
untreated or following fixation with paraformaldehyde. DCs used in co-cultures were untreated, preincubated with blocking 
anti-CD162 mAb to prevent PLT binding when placed in the same well, or preincubated with suramin in order to block ATP 
receptors. DCs were then stained for CD1a and CD80, CD86, CD83, or CD40 and analyzed by flow cytometry. The flow 
cytometry plots are gated on CD1a+ cells only. PLTs cultured without DCs (untreated), after thrombin activation, and after co-
culture with DCs in separate or the same compartments were stained for CD41 and CD62P. (A) Representative results of five 
independent experiments and (B-D) mean values ± SD of three independent experiments for suramin, blocking anti-CD162 
mAb, and fixed PLTs conditions, and of five independent experiments for the other conditions. Mean values for activation 
marker expression by DCs co-cultured with PLTs are summarized (B) and developed for co-culture in the same well (C) and 
for filter-separated co-culture (D). Percentages of marker expression in each experiment were assessed in triplicate. Asterisks 
indicates statistical significance between assay and untreated DCs a p < 0.05 (*) or < 0.005 (**) by Mann-Whitney U test.BMC Immunology 2008, 9:54 http://www.biomedcentral.com/1471-2172/9/54
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Cytokine and chemokine production in dendritic cell-platelet co-culture Figure 4
Cytokine and chemokine production in dendritic cell-platelet co-culture. Dendritic cells (DCs) were cultured for 48 
h alone (untreated), with sCD154, or with untreated or fixed platelets (PLTs) either in two 0.4-μm pore-sized filter-separated 
compartments or in the same compartment, with or without blocking anti-CD162 mAb or suramin. Thrombin-treated PLTs 
were used as positive controls for cytokine and chemokine release by activated PLTs. Supernatants were collected and TNFα 
(A), IL-1β (B), IL12-p70 (C), and RANTES (D) production was assessed by the Luminex® technology. Histograms represent 
mean values ± SD of three independent experiments, with each experiment assessed in triplicate. Asterisks indicates statistical 
significance between assay and untreated DCs a p < 0.05 (*) or < 0.005 (**) by Mann-Whitney U test.
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ture supernatant could be due to production by DCs. We
extracted RANTES mRNA from DCs and PLTs cultured
alone and from DCs and PLTs co-cultured together or in
filter-separated compartments. There was no increase in
RANTES mRNA in DCs cultured with PLTs in the same
compartment as compared to the other culture conditions
(Figure 5). Interestingly, DCs in direct contact with PLTs
synthesized even less RANTES mRNA, suggesting that
RANTES found in the supernatant from direct contact co-
culture of DCs and PLTs is released by PLTs rather than by
DCs and that contact between these two cell types may
reduce RANTES mRNA synthesis in DCs.
Autologous T cell activation
Next, we investigated the capacity of DCs co-cultured with
PLTs to induce autologous CD4+ T cell proliferation in a
mixed leukocyte reaction using CFSE labeling. CFSE is a
stable cytoplasmic fluorescent dye that segregates equally
between daughter cells upon cell division. Thus, the rela-
tive intensity of the dye decreases and dividing cells are
characterized by their low CFSE content (CFSElow cells). As
a positive control, we stimulated CD4+ T cells with IL-2
and PHA and observed an increase in CFSElow cells as
compared to untreated T cells (Figure 6A). We assessed the
DC induction of T cell proliferation as described in Meth-
ods section.
We observed that PLTs co-cultured in direct contact with
DCs, although they induced neither significant overex-
pression of costimulatory molecules nor IL-12(p70) pro-
duction by DCs, could stimulate DCs enough to trigger a
significant T cell proliferation as compared to DCs alone,
24 ± 5% and 7 ± 1% respectively (Figure 6B). This T cell
proliferation was prevented when PLTs were fixed with
paraformaldehyde but not when DCs were treated with
suramin or blocking anti-CD162 mAb (Figure 6B), indi-
cating that (i) DC stimulation by PLTs in the same well
occurs via the release of a soluble factor, (ii) nucleotides
such as ADP or ATP are not involved, and (iii) PLT bind-
ing on DCs is not critical for the release of this factor. In
addition, during filter-separated co-culture, PLTs stimu-
lated DCs more efficiently in terms of induction of T cell
proliferation (43 ± 10%; Figure 6B), in agreement with
the phenotypic activation of DCs and IL-12 production. T
cell proliferation induced by DCs from filter-separated co-
culture with PLTs relied on PLT-release of nucleotides,
because PLT fixation and suramin-treatment of DCs pre-
vented T cell proliferation.
Finally, we checked IL-2 and IL-4 production during
autologous T cell activation in order to evaluate Th-polar-
ization. Under each condition that induced efficient T cell
proliferation, IL-2 production was completely abolished
and a significant amount of IL-4 was produced (Figure
6C), suggesting Th2 polarization of T cells by PLT-stimu-
lated DCs. However, while DCs from filter-separated co-
culture with PLTs could induce T cell proliferation, signif-
icant IL-4 production paralleling the inhibition of IL-2
production was not detected, implying the involvement
of other cytokines. Nevertheless, we can hypothesize that
the inhibition of IL-2 production would favor a Th2 rather
than a Th1 response.
Taken together, these observations suggest that direct con-
tact between PLTs and DCs does not induce a phenotypic
activation of the DCs but does polarize DCs to become
Th2-inducing cells, whereas filter-separated PLTs induce a
functional maturation of DCs marked by IL-12 produc-
tion and inhibits DC polarization toward Th1-inducing
cells.
Discussion
Platelets express numerous cell surface molecules, such as
intercellular adhesion molecule (ICAM)-2, CD62P, and a
RANTES mRNA analysis in dendritic cell-platelet co-culture Figure 5
RANTES mRNA analysis in dendritic cell-platelet co-
culture. Dendritic cells (DCs) were cultured for 48 h with 
sCD154 or with platelets (PLTs) either in two 0.4-μm pore-
sized filter-separated compartments or in the same compart-
ment. As culture negative controls, DCs or PLTs were cul-
tured alone for 48 h (untreated DCs, untreated PLTs). The 
positive PCR control consisted of a synthetic double-
stranded DNA provided by the manufacturer, the negative 
PCR control consisted of water instead of cDNA template 
for PCR. Data are representative of three independent 
experiments.
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large range of glycoproteins that play a part in cell-to-cell
interactions, including binding. Indeed, previous studies
have shown that PLTs bind to T lymphocytes via a CD11a/
ICAM-2 interaction [23], and bind to neutrophils and
monocytes via CD62P/CD162 interaction [24,25].
We observed efficient binding of PLTs to DCs when these
two cell types were cultured together, with nearly half of
the DCs bearing PLTs (Figure 1D). We also showed that
DCs interact with PLTs via CD162 but not via CD209 (Fig-
ure 2B). Although CD209 has been shown to interact with
ICAM-2 during DC emigration from blood [26], we did
not detect any significant binding of PLT ICAM-2 to
CD209-expressing DCs. This could be explained by the
sialylation of ICAM-2 on platelets, which has been
reported to decrease the efficiency with which PLTs bind
to CD209 [27]. In addition, PLTs display numerous mem-
brane glycoproteins [28] and DCs display many mem-
brane lectins [3] that could also be involved in PLT-DC
binding.
Autologous T cell activation by dendritic cells co-cultured with platelets Figure 6
Autologous T cell activation by dendritic cells co-cultured with platelets. Untreated dendritic cells (DCs) or DCs 
co-cultured for 48 h with platelets (PLTs) either in the same well or in filter-separated compartments were co-cultured with 
autologous CD4+ T cells stained with carboxyfluorescein diacetate succinimidyl ester (CFSE). After 7 days of co-culture, T cell 
proliferation was determined by the percentage of CFSElow cells (B) and culture supernatants were recovered and analyzed for 
IL-2 and IL-4 content (C). (A) Represents typical FACS histograms of CFSE staining of untreated or IL-2+ PHA-stimulated CD4+ 
T cells. (B) Percentage of CFSElow T cells in co-culture with DCs was calculated according to the following formula described in 
the Methods section. (B, C) values are mean ± SD of three independent experiments, with each experiment assessed in dupli-
cate. Asterisks indicates statistical significance between assay and untreated DCs at p < 0.05 (*) or < 0.005 (**) by Mann-Whit-
ney U test.
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Further, we investigated the nature of DC-PLT interactions
using two co-culture models: filter-separated and direct-
contact co-culture. Filter-separated co-culture of these two
cell types resulted in DC activation accompanied by sig-
nificant overexpression of costimulatory molecules that
could have been influenced by the release of a soluble fac-
tor by PLTs (Figure 3D). Interestingly, Kissel et al. [29]
reported that PLTs, activated or not, could not induce DC
maturation. It is possible that their observations were the
result of a lack of reversion in DC activation status rather
than the inhibition of DC activation, as their DCs were
activated with LPS prior to co-culture with PLTs.
In vivo studies have shown that PLTs can recruit leukocytes
in murine models of glomeruli inflammation [30], aller-
gic lung inflammation [31], contact hypersensitivity [32],
and acid-induced acute lung injury [33], and that this
recruitment was due to CD62P expressed by activated
PLTs. Similarly, Elzey et al. demonstrated in vivo that the
expression of CD154 on PLTs was required to induce B
cell isotype switching, augment CD8+ T cell responses,
and induce DC maturation in mice [10]. Langer et al. also
demonstrated PLT-induced DC activation in vitro, but the
PLT activation state was not discussed in this report [34].
These observations underline the fact that activated PLTs
can generate immune responses.
Because PLTs have been described to liberate large
amounts of sCD154, representing most of the circulating
sCD154 [35,36], we investigated whether DC activation
could be related to PLT-derived sCD154, as has been
shown in other studies of DCs [37], B cells [38], and T
cells [10]. We also searched for PLT-derived sCD62P in co-
culture supernatants, because sCD62P has been shown to
induce monocyte differentiation into dendritic-like cells
[39] and to induce polymorphonuclear cell activation
[40]. In our culture conditions, no sCD154 or sCD62P
was detected (data not shown), suggesting the involve-
ment of other PLT-derived factor(s). In fact, previous stud-
ies showing that PLT-derived sCD154 induced leukocyte
activation used thrombin-activated PLTs. In our hands, no
PLT activation was observed during filter-separated co-
culture, which could explain the lack of sCD154 release.
These observations agree with those of Hagihara et al.,
who showed that an unidentified soluble factor (which
was not sCD154), excreted by high shear-exposed plate-
lets could mature DCs in vitro [41]. Indeed, PLTs contain
many soluble factors that could play a role in DC matura-
tion, such as growth factors, Platelet Factor 4, β-throm-
boglobulin [42], ATP [17], and proinflammatory
chemokines [43]. When we treated DCs in filter-separated
co-culture with PLTs with suramin, a broad-spectrum P2
receptor antagonist, costimulatory molecule expression
on DCs was restored to its initial level, supporting the
hypothesis that PLT-derived nucleotides are involved in
DC activation (Figure 3D).
Quantifying ATP release by PLTs would be particularly
useful for our model. However, measuring ATP released
into culture supernatants is not straightforward – P2
receptors can bind up nucleotides in the medium and
ecto-nucleotidases on DCs can rapidly hydrolyze extracel-
lular ATP [44]. Furthermore, ATP measurement requires
specific bioluminescence assay equipment [45]. However,
low concentrations of extracellular ATP were shown to
increase CD80, CD86, and CD83 expression on DCs,
which is consistent with our results [21].
The activated phenotype exhibited by DCs in filter-sepa-
rated co-culture with PLTs was associated with their func-
tional activation, as assessed by their increased IL-12(p70)
production (Figure 4C) and their induction of autologous
T cell proliferation. The T cell proliferation was prevented
by suramin-treatment, confirming the role of PLT-derived
nucleotides in DC activation (Figure 6B).
Our results contrast with those of Kissel et al., who
reported PLT-induced inhibition of IL-12(p70) produc-
tion. However, Kissel et al. used LPS to stimulate IL-
12(p70) production by DCs. Nonetheless, we must con-
sider that PLTs express functional TLR4, which could
explain the differential modulation of DC maturation
[9,46]. In contrast to the observed increase in IL-12(p70)
production, we observed no significant increase in TNFα
or IL-1β production related to PLT-induced DC activation,
as was expected [47,48]. These observations correlate par-
tially with those of La Sala et al., who demonstrated that
low doses of extracellular ATP induced a phenotypic acti-
vation of DCs but inhibited LPS- and sCD154-dependent
production of IL1-β, TNF-α, and IL-12(p70) [21]. These
discrepancies concerning IL-12(p70) could be due to var-
iations in the dosage of ATP: La Sala et al. used low con-
centrations of extracellular ATP while we relied on PLT
release of ATP, which is known to be substantial. Moreo-
ver, we cannot exclude the possibility that PLTs released
other soluble factors(s), such as arachidonic acid metabo-
lites [49], that could modulate the effects of ATP on DC
activation, as has been observed for prostaglandin D2 in
the inhibition of Langerhans cell migration [50].
In addition, we observed that co-culture of PLTs with DCs,
either in direct or indirect contact, did not induce PLT acti-
vation and no sCD154 was released into the supernatants.
Yet, we postulate that PLTs cultured in a separate compart-
ment from DCs, while not displaying an activated pheno-
type, release nucleotides that activate DCs. Indeed, we
showed that upon a short-delay storage (1–2 days), PLTs
released several factors such as PDGF-AA and TGF-β [19]
without any significant change in CD62P expression.BMC Immunology 2008, 9:54 http://www.biomedcentral.com/1471-2172/9/54
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Thus, we can assume that non-activated PLTs release base-
line amounts of nucleotide, such as ADP and ATP, which
can be prevented by direct contact with DCs.
Direct contact between these two cell types seems to pre-
vent DC maturation, as no significant increase in costim-
ulatory molecule expression by DCs during co-culture
(Figure 3C). Notably, under these conditions DCs express
higher levels of CD80 than CD86, which seems to be
related to a "tolerogenic" DC phenotype. It was previously
shown that CD80 and CD86 differentially modulate the
suppressive function of regulatory T cells, with CD80
enhancing the Treg suppressive function and CD86 inhib-
iting the Treg suppressive function [51]. Without going so
far, these observations suggest that direct contact between
PLTs and DCs does not result in DC activation, but may
promote a DC phenotype related more to a "tolerogenic-
like" state than to an "activating" state.
The non-activated phenotype observed when DCs were in
direct contact with PLTs was associated with a lack of IL-
12(p70) production and the inhibition of IL-1β and TNFα
production (Figures 4 A-B). However, mechanisms for
inhibiting IL-1β and TNFα production seemed to differ
from one another. Whereas the inhibition of TNFα pro-
duction relied on PLT binding to DCs exclusively (Figure
4A), inhibition of IL-1β production seemed to be based
on nucleotide release by PLTs upon binding to DCs (Fig-
ure 4B).
We noted a significant increase in the amount of RANTES
in the direct co-culture supernatant, but less so than that
observed when DCs were treated with sCD154 or when
PLTs were treated with thrombin (Figure 4D). This
increase in RANTES was linked to a slight decrease in
RANTES mRNA in DCs (Figure 5). These observations,
associated with the lack of RANTES when PLTs were fixed
with paraformaldehyde, strongly suggest that RANTES
was released by platelets upon contact with DCs. Finally,
we observed that while DCs in direct contact with PLTs
neither exhibited an activated phenotype nor produced
IL-12(p70), they could stimulate autologous T cell prolif-
eration, although to a lesser extent than DCs cultured sep-
arately from PLTs (Figure 6B). However, we found that IL-
2 production was inhibited and IL-4 secretion was
increased when DCs were in close contact with PLTs prior
to the mixed lymphocyte reaction (Figure 6C), suggesting
that these DCs were polarized to induce Th2 rather than
Th1 responses. As for DCs in filter-separated co-culture
with PLTs, although no significant IL-4 production was
observed, the inhibition of IL-2 production favors Th2
polarization. These observations agree in part with those
of La Sala et al. who demonstrated that ATP-activated DCs
produced lower amounts of IFN-γ and higher levels of IL-
4 [21]. However, the mechanism involved in DC-induced
T cell proliferation seems to be different depending on DC
were whether in direct contact or filter-separated from
PLTs. Although a soluble factor was involved (PLT fixation
inhibited IL-4 and restored IL-2 production), it does not
appear that this factor was ATP because suramin-treat-
ment of DCs did not inhibit IL-4 production. Moreover,
treatment with blocking anti-CD162 mAbs did not induce
the same cytokine profile as culturing the two cell types in
separate compartments, suggesting that the DC micro-
environment might influence factor release by PLTs and
indicating an increasingly complex pattern of interaction
between the two cell types.
Conclusion
In conclusion, we demonstrated that PLTs bind to DCs via
the CD162 receptor and that cell-to-cell contact between
PLTs and DCs and filter-separated co-culture have oppos-
ing effects on DC maturation. During culture in separated
compartments, non-activated PLTs spontaneously release
nucleotides (but not sCD154) that induce DC functional
activation. Conversely, by preventing the release of nucle-
otides by PLTs, direct contact between DCs and PLTs nei-
ther activates PLTs nor promotes DC activation but
induces polarization towards a Th2 response. This work
emphasizes the importance of continued study of the
interactions between PLTs and DCs, key elements to be
taken into account in transfusion practices.
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